- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Stefan Platz, Roche
I started off as a pathologist at Boehringer-Ingelheim in Germany.
Stefan Platz
Head of Toxicology, Non-Clinical Safety Global Head, Early Safety, Roche
I started off as a pathologist at Boehringer-Ingelheim in Germany. When I accepted the position as the head of Non-Clinical Safety in Palo Alto, CA, and moved from a classical German culture to Silicon Valley, I was amazed by the speed and the innovative culture around me. It was a very stimulating and interesting environment.
There is the expectation that younger leaders will come into the industry with a more creative mindset, open to new ideas and concepts of innovation. There are many exciting innovations likely to occur in the coming years, especially in the development of new technologies. One very interesting emerging technology is the field of small interfering RNA (siRNA). Compared to small molecules, siRNA offers the opportunity to be more selective and potent against a well-defined target.
I sought a career to find cures to diseases and help patients around the world. It was and still is enticing to be part of a team that develops drugs that one day will save lives.
FDA Approves Roche’s Susvimo Refillable Eye Implant for Diabetic Macular Edema
February 4th 2025Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing sustained vision improvements with fewer treatments than standard eye injections.
The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations
January 30th 2025Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses how to combat the spread of misinformation on social media, opportunities that social media presents, advancements in fertility technology, and more.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
